The effect of cGMP on noradrenaline-induced intracellular Ca# + mobilization was investigated in whole-cell voltage-clamped guinea-pig hepatocytes. Treatment of the cells with 8-Br-cGMP (1-500 µM) resulted in an increase in the sensitivity of the cells to noradrenaline and to inositol 1,4,5-trisphosphate (InsP $ ) photoreleased from caged InsP $ . The positive effect of 8-Br-cGMP on the Ca# + release evoked by Ca# + -mobilizing agonists or InsP $ was blocked by a protein kinase G (PKG ; cGMP-dependent protein kinase) inhibitor, the R-8-(4-chlorophenylthio)guanosine 3h :5h-monophosphorothioate. 8-Br-cGMP affected neither the basal InsP $ concentration nor the noradrenaline-induced production
INTRODUCTION
Several studies indicate that cGMP is an intracellular second messenger involved in the regulation of the intracellular free Ca# + concentration ([Ca# + ] i ) in vascular smooth muscle. Its association with a cGMP-dependent protein kinase (PKG) has been shown to mediate nitric oxide (NO)-induced or natriuretic peptideinduced vascular smooth muscle relaxation (reviewed in [1] ). Several smooth muscle cell functions are affected by cGMP and their modification appears to account for the effect of cGMP on the vascular reactivity [2] . Among these, a cGMP-dependent inhibition of the inositol 1,4,5-trisphosphate (InsP $ )-induced Ca# + release was described [3] and was correlated with the phosphorylation of the InsP $ receptor induced by agents known to increase the intracellular cGMP concentration [4] . It is also known that cAMP-dependent phosphorylation of brain and liver InsP $ receptors have opposite effects and respectively inhibit or potentiate the InsP $ -induced Ca# + release [5] [6] [7] [8] . For this reason, we have investigated the effects of cGMP on the release of Ca# + from InsP $ -sensitive stores in hepatocytes. The variations of [Ca# + ] i were monitored in whole-cell voltageclamped guinea-pig hepatocytes using either the well-characterized Ca# + -dependent K + conductance [9] or furaptra, a Ca# + -dependent fluorescent dye loaded from the patch pipette. We have studied the effect of cGMP on the release of Ca# + from the InsP $ -sensitive stores evoked by a Ca# + -mobilizing agonist, i.e. noradrenaline (via the α " -adrenoceptors), and InsP $ photoreleased from a caged precursor. Our results show cGMP pretreatment of the cells was able to potentiate the release of Ca# + from InsP $ -sensitive stores. Furthermore, we have shown that the cGMP-evoked effects were blocked by inhibitors of 
EXPERIMENTAL
Guinea-pig liver cells (male of the Hartley strain, 200-250 g) were dispersed after enzymic digestion as described previously [9, 10] . Freshly dissociated hepatocytes (approx. 400 000 cells) were plated in 35-mm-diam. Falcon dishes in 2 ml of William's E medium supplemented with fetal-calf serum (10 %, v\v), penicillin (200 000 units\ml) and streptomycin (100 mg\ml), and kept at 37 mC in an atmosphere of CO # (5 %) in air.
Whole-cell recording
Standard tight-seal whole-cell recording techniques were used [11] . Patch pipette resistances were typically 5 MΩ. Whole-cell currents were measured with a Biologic RK300 patch-clamp amplifier, digitized by a CED 1401 interface (CED Ltd) and analysed by using the VCAN package supplied by J. Dempster (University of Strathclyde, U.K. 3). The dish was thermostatically maintained at 34 mC and continuously perfused. All the solutions were filtered through a 0.22-µm-poresize Millipore filter.
Fluorescence measurements and flash photolysis
We used the same experimental set-up as described previously [12, 13] . Furaptra (potassium salt) and the caged compounds were introduced into the cell by diffusion from the patch pipette. A period of 5-6 min was required for equilibration of the furaptra fluorescence signal. [Ca# + ] i was derived from fluorescence signals using a method described previously [12, 13] . Photolysis of caged InsP $ [P-5 1-(2-nitrophenyl)ethyl ester InsP $ ] was produced by a 1 ms pulse from a xenon arc flashlamp [14] focused through a UG11 filter (280-360 nm) from 4 cm above the cell to produce a 4-5 mm spot [15] . The method to assess the amount of InsP $ released per flash has been described previously [13] . The optical artefact arising from the UV pulse was minimized (4-8 ms) by use of quartz coverslips and UV block oil between the coverslip and the objective [15, 16] .
Measurement of InsP 3
The cellular InsP $ content was measured according to the method of Combettes et al. [17] with small modifications. Briefly, cells were incubated (3i10' cells\ml) for 90 min in the William's E medium containing [$H]myo-inositol (30 µCi, 1 mCi\mmol). The cells were washed and resuspended (5i10' cells\ml) in a medium containing (mM) : NaCl, 106 ; KCl, 5.6 ; CaCl # , 1.8 ; MgCl # , 1.2 ; LiCl, 10 ; NaHCO $ , 10. Aliquots (1 ml) were incubated at 37 mC under carbogene for 1 min, then treated with noradrenaline (10 µM, 2 min), or with 8-Br-cGMP (1 mM, 5 min), or with both 8-Br-cGMP (1 mM, 5 min) and noradrenaline (10 µM, 2 min). The reactions were stopped with 2 ml of perchloric acid (3.3 % final concentration, 4 mC, 30 min). The supernatants were neutralized with saturated KHCO $ and diluted with 5 mM Na # B % O ( \0.5 mM EDTA. The $H-labelled inositol phosphates were separated by anion-exchange chromatography on a Dowex AG X8 column (0.5 cmi3 cm ; formate form 100-200 mesh ; Bio-Rad).
Ca 2 + release from saponin-treated cells
Hepatocytes were permeabilized by saponin as reported previously [18] . Briefly, cells were centrifuged and washed twice (50 g for 1 min) with an Eagle's medium lacking Ca# + , then resuspended (3i10' cells\ml) in a cytosol-like medium containing : 100 mM KCl, 20 mM NaCl, 5 mM MgCl # , 1 mM NaH # PO % , 25 mM Hepes buffer (pH 7.2 at room temperature), 1.5 mM Na # ATP, 5 mM creatine phosphate, 5 units\ml creatine kinase and 20-40 µM fluorescent Ca# + buffer quin2, in the presence of a contaminating Ca# + concentration of a few micromolar plus endogenous Ca# + . Cells were transferred to the spectrofluorimeter cuvette under continuous stirring. Saponin was added at a final concentration of 50 µg\ml to allow permeabilization of the plasma membrane but not of the internal Ca# + stores, which retained their capacity for active accumulation of Ca# + . After this treatment, about 90 % of the cells were permeable to Trypan Blue. The cell Ca# + content was determined as previously published [18] and expressed as nmol of Ca# + \mg of cell protein from the difference between the Ca# + bound to quin2 before and after addition of the agent. Ionomycin (5 µM) was used to determined the size of the total Ca# + compartment.
Chemicals
All the chemicals were from Sigma except InsP $ (Amersham Corp.), quin2 and furaptra (Molecular Probes Inc.), Williams' E medium (Gibco) and 8-Br-cGMP, R-8-(4-chlorophenylthio)-guanosine 3h :5h-monophosphorothioate (Rp-8-pCPT-cGMPS) and R-8-(4-chlorophenylthio)adenosine -3h :5h-monophosphorothioate (Rp-8-pCPT-cAMPS) (Biolog, Germany). CagedInsP $ was generously given by Dr. D. R. Trentham.
RESULTS
The plasma membrane of guinea-pig hepatocytes possesses K + channels that are activated by an increase of intracellular Ca# + upon stimulation by Ca# + -mobilizing hormones or neurotransmitters [9, 10] . It has been previously shown that this Ca# + -activated K + conductance closely follows the responses obtained using Ca# + fluorescent dyes and therefore can be used to monitor the variations in [Ca# + ] i in whole-cell voltage-clamped guinea-pig hepatocytes [12, 13, 15] . We sometimes used the Ca# + dye furaptra to simultaneously monitor the increases in [Ca# + ] i and in the Ca# + -dependent K + conductance. This confirmed that, in our study, the activation of the Ca#
cGMP potentiates the noradrenaline-induced Ca 2 + increases
Ca# + mobilization by hormones or neurotransmitters is often characterized by a marked delay that shortens at increased concentrations of agonists [19] . This delay is mainly due to the time taken to accumulate a sufficient local concentration of the second messenger InsP $ or Ca# + to set off a regenerative response [20, 21] . Figure 1 shows the Ca# + -dependent K + conductance due 
Figure 1 Activation of the Ca 2 + -dependent K + current by increasing concentrations of noradrenaline in guinea-pig hepatocytes
The cell was sequentially perfused with increasing concentrations of noradrenaline (0.3 to 10 µM) applied along horizontal bars. The delay (horizontal arrows) is defined as the latency between the addition of noradrenaline and the activation of the Ca 2 + -dependent K + conductance. Holding potential k40 mV. cGMP-enhanced Ca 2 + mobilization in liver to the variations of [Ca# + ] i of a single guinea-pig hepatocyte after sequential addition of five different concentrations of noradrenaline. The cell perfusion by a low concentration of noradrenaline (i.e. 0.3 µM) did not result in the activation of the Ca# + -dependent K + conductance, at least not during the time of perfusion (2 min). Increasing the noradrenaline concentration to 0.5 µM promoted the activation of the K + current due to an increase in [Ca# + ] i after 65 s. Further increases in the noradrenaline concentration resulted in the decrease of the lag time between the onset of the agonist and the appearance of the response (65, 46 and 27 s at respectively 1, 5 and 10 µM noradrenaline). The sequence shown in Figure 1 was observed in four different cells, the main difference between these cells being the threshold concentration of agonist which varied from 0.1 to 0.5 µM. Thus a low concentration of noradrenaline is likely to trigger, if any, a response with a long delay and it was therefore interesting to investigate how cGMP would affect this response in guinea-pig hepatocytes. The results presented in Figure 2 illustrate the effect of cGMP on the response induced by 0.1 µM noradrenaline in two different cells both voltage-clamped at k40 mV. An application of 0.1 µM noradrenaline for 3 min was ineffective on the first cell ( Figure 2A ). The cell was washed for 2 min in the absence of neurotransmitter and then perfused for the next 3 min with 500 µM 8-Br-cGMP (a permeant analogue of cGMP that is poorly hydrolysable). The K + conductance remained inactive until the addition of 0.1 µM noradrenaline in the external medium. A transient increase of the K + current was observed 50 s after the reintroduction of the agonist in the external medium. This activation appeared to be related to the presence of 8-Br-cGMP, since a subsequent perfusion by noradrenaline alone later on the same cell did not result in a similar The cell was treated as indicated in Figure 1 except that noradrenaline (NOR, 1 µM) was added in a Ca 2 + -free medium. Holding potential k40 mV. This trace is representative of three cells tested.
activation of the Ca# + -dependent K + current. On a second cell ( Figure 2B ), 0.1 µM noradrenaline evoked a transient increase in the K + current with a delay of 95 s. In the presence of 500 µM 8-Br-cGMP added 2 min before the neurotransmitter, 0.1 µM noradrenaline also led to an increase in K + current, this time with a much shorter delay of 7 s. The presence of 8-Br-cGMP changed the pattern of the response from repetitive spikes to a sustained plateau, a change that was also observed when the noradrenaline concentration was increased from 0.1 to 5-10 µM in the absence of 8-Br-cGMP. The potentiation by cGMP of the noradrenalineevoked responses was observed in six out of seven cells tested.
cGMP does not require external Ca 2 + to potentiate the noradrenaline-induced response
The increase of intracellular Ca# + induced by noradrenaline is supported by the release of Ca# + from internal stores but also by an influx of Ca# + from the external medium. It is possible that the potentiating effect of cGMP on the noradrenaline-evoked activation of the Ca# + -dependent K + conductance may be due to an enhanced entry of Ca# + into the cytosol independently or not of internal Ca# + release. This increased Ca# + entry may be due to an effect of cGMP on noradrenaline-activated Ca# + influx or cGMP itself independently of noradrenaline [22] [23] [24] . We have examined the effect of 8-Br-cGMP on the response induced by submaximal concentrations of noradrenaline in the absence of external Ca# + . The protocol was the same as in Figure 2 except that noradrenaline (1 µM) was added in a Ca# + -free medium. 8-Br-cGMP (500 µM) was added 2 min before the agonist in a Ca# + -containing medium to avoid a partial depletion of the internal Ca# + stores. Then, 1 µM noradrenaline was perfused on the cell in a Ca# + -free medium to block the Ca# + influx but still in the presence of cGMP. Figure 3 shows that the potentiating effect of cGMP on the intracellular Ca# + increase remains unaffected in the absence of external Ca# + as this was observed in all three of the cells tested. This strongly suggested that the cGMP potentiation of the noradrenaline responses in guinea-pig hepatocytes probably reflect an enhanced Ca# + release from the internal stores.
We have verified that the potentiation by 8-Br-cGMP of the noradrenaline-evoked responses was not due to an increase in the InsP $ production in the presence of the cyclic nucleotide. This was done as indicated in the Experimental section and the results 
Figure 4 Stimulation by 8-Br-cGMP of the response induced by noradrenaline is mediated through the activation of a cGMP-dependent protein kinase
The three traces were obtained from three different cells ( are presented in Table 1 . The incubation of a guinea-pig liver cell suspension with 10 µM noradrenaline for 2 min significantly increased the InsP $ content of the cells, whereas 1 mM 8-BrcGMP for 5 min had no detectable effect. Furthermore, the preincubation of the cell suspension with 1 mM 8-Br-cGMP for 5 min had no effect on the InsP $ production evoked by noradrenaline (10 µM for 2 min). These results indicated that the potentiation of the noradrenaline responses by cGMP is unlikely to reflect an activation of the phosphoinositidase C by the cyclic nucleotide.
cGMP stimulates the noradrenaline-induced rise of intracellular Ca 2 + through the activation of a cGMP-dependent protein kinase
The results presented above indicated that cGMP might stimulate the release of Ca# + from internal stores induced by noradrenaline. We have investigated the mechanism by which cGMP acts on this release. As reported in [1] , cGMP can interact with several cGMP-binding proteins in order to mediate its intracellular effects. Among these, a cGMP-dependent protein kinase (PKG) has already been described in hepatocytes, although it is present in low amounts (for a review, see [25] ). PKG may mediate the effect of cGMP on release of Ca# + induced by noradrenaline. To test this hypothesis, we applied Rp-8-pCPT-cGMPS, which is a membrane-permeant and phosphodiesterase-resistant inhibitor of the PKG Ia (K i l 240 nM, [26] ). We compared the effect of 8-Br-cGMP on the noradrenaline-triggered Ca# + release in the presence or absence of the inhibitor and the results are shown in Figure 4 (A). First, as shown above, we observed that 0.3 µM noradrenaline evoked a Ca# + release in the presence of 10 µM 8-Br-cGMP, whereas the cell remained quiescent in its absence. The two drugs were washed away for 3 min then we sequentially added the PKG inhibitor Rp-8-pCPT-cGMPS (5 µM) alone for 2 min, then together with the PKG activator 8-Br-cGMP (10 µM) for 3 min, and finally with 0.3 µM noradrenaline. In these conditions, the potentiation by cGMP of the agonist response was blocked, an effect directly linked to the presence of the PKG inhibitor since the noradrenaline response was recovered after its removal. We also investigated the efficiency of 5 µM Rp-8-pCPT-cGMPS to block the cGMP-dependent stimulation when the 8-Br-cGMP concentration was raised to 500 µM ( Figure 4B ). In that case, Rp-8-pCPT-cGMPS failed to totally block the potentiating effect of 8-Br-cGMP, but increased the delay of the noradrenaline-evoked response.
We have also investigated a role for cAMP-dependent protein kinase (PKA) in the stimulation by cGMP. Indeed, the results presented above could be explained if PKA was non-specifically activated by cGMP, since an enhancement of the Ca# + release from intracellular stores by PKA has already been described [7, 27] . This possibility was investigated by using a membranepermeant inhibitor of PKA (Rp-8-pCPT-cAMPS). The results are illustrated in Figure 4 (C). The cell was perfused as described in Figure 4 (A), except that Rp-8-pCPT-cGMPS was replaced by Rp-8-pCPT-cAMPS. Under these conditions, the potentiation of the noradrenaline-induced response by 8-Br-cGMP was identical whether the PKA inhibitor was present or absent. Thus, our results indicate that the stimulation of the noradrenaline-induced response by cGMP is likely to be mediated through the activation of PKG.
cGMP stimulates the release of Ca 2 + induced by the photolysis of caged-InsP 3 Komalavilas and Lincoln [4] have reported that the InsP $ receptors of smooth muscle are phosphorylated by PKG and cGMP-enhanced Ca 2 + mobilization in liver proposed that this phosphorylation may modify the properties of the InsP $ receptor. Although, the predominant isoforms of InsP $ receptors present in the hepatocyte and in the smooth muscle are likely to be different [28] , a cGMP-dependent phosphorylation of the InsP $ receptor could represent the molecular basis of our observations. This led us to compare the Ca# + release induced by InsP $ in the presence or absence of 8-Br-cGMP. This was done by photoreleasing InsP $ from 5 µM caged InsP $ introduced into the cell via the patch-pipette together with 500 µM furaptra. The output energy of the flash lamp was adjusted to convert about 6 % of the caged InsP $ per flash [13] . The InsP $ -induced Ca# + releases from the internal Ca# + stores are characterized by a delay and a fast rise in guinea-pig hepatocytes, endothelial cells or cerebellar Purkinje neurons [12] . The response to three successive photoreleases of InsP $ before, during and after the perfusion of 1 µM 8-Br-cGMP is shown in Figure 5 . The photorelease of 300 nM InsP $ into the cell had no effect on the Ca# + -dependent K + conductance and the release of Ca# + from the internal stores unless 1 µM 8-Br-cGMP was present. This potentiating effect of cGMP on the InsP $ -evoked Ca# + release was observed in all the six cells tested. These results strongly suggested that a change in the InsP $ receptor affinity was likely to be responsible for the potentiating effect of cGMP described here. These results also confirmed that the activation of the Ca# + -dependent K + conductance mimicks the [Ca# + ] i increases and therefore can be used to monitor the variations in [Ca# + ] i in guinea-pig hepatocytes.
cGMP induced an increase in the InsP 3 receptor affinity for InsP 3 The experiments in intact cells suggested that, in the presence of cGMP, subthreshold concentrations of InsP $ were able to increase [Ca# + ] i . In order to investigate this phenomenon in more detail, we examined the effect of cGMP on Ca# + release from the intracellular stores using saponin-treated hepatocytes. Addition of a submaximal InsP $ concentration (0.2 µM) led to a rapid release of Ca# + into the medium which was buffered by the cells within 3 min ( Figure 6A ). After the re-accumulation of Ca# + to the resting value, addition of cGMP (1 mM) to the same cells did not induced any effect on steady-state buffering of Ca# + by the cells. However, addition of 0.2 µM InsP $ to these cells induced a larger release of Ca# + (167p18 %, n l 8), compared with the first addition of the same InsP $ concentration taken as reference (i.e. 100 %)( Figure 6A ). This effect resulted from the 8-Br-cGMP action since, using the same protocol, a second addition of InsP $ (0.2 µM) in the absence of 8-Br-cGMP released the same amount of Ca# + (96p8 %, n l 5). It was worth noting that the 8-BrcGMP action was time-and concentration-dependent, the potentiation of the InsP $ -induced Ca# + release in the presence of 1 mM 8-Br-cGMP was maximal after 4 min and no effect was observed for concentrations below 500 µM 8-Br-cGMP (results not shown).
Finally, the amount of Ca# + release by 5 µM ionomycin was the same in the absence or in the presence of 8-Br-cGMP, being respectively 0.85p0.05 versus 0.93p0.06 nmol of Ca# + \mg of protein. Also, the size of the InsP $ -sensitive compartment was not affected in the presence of 8-Br-cGMP and corresponded to about 70 % of the ionomycin-sensitive compartment ( Figure  6B ). Figure  6B ).
DISCUSSION
The work described in this paper shows that cGMP potentiates the noradrenaline-induced Ca# + mobilization in freshly isolated guinea-pig hepatocytes. Our results provide evidence that this effect results, via the action of PKG, from an increase in the sensitivity of the InsP $ receptors to InsP $ .
cGMP potentiation of noradrenaline-induced [Ca 2 + ] i increases
The noradrenaline-evoked rise in [Ca# + ] i monitored by the guineapig Ca# + -dependent K + conductance is deeply modified in the presence of cGMP. Such results could have resulted if the properties of Ca# + -dependent K + channels were (directly or not) modified by cGMP [29] . Here, the experiments done with furaptra showed that cGMP stimulates the InsP $ -evoked Ca# + release, resulting in a shorter delay in the activation of the K + conductance. The source of the Ca# + for this increase in [Ca# + ] i is intracellular, since improved Ca# + responses enhanced by cGMP were observed in the absence of extracellular Ca# + . Several mechanisms, alone or together, could provide an explanation for the observed potentiation. The cGMP pretreatment could : (i) enhance the production of the putative Ca# + -mobilizing second messenger InsP $ ; (ii) increase the size of the agonist-releasable intracellular store(s) ; or (iii) increase the sensitivity of the Ca# + stores to the Ca# + -mobilizing effects of InsP $ . We can rule out the first hypothesis since, in the present work, the InsP $ production was not affected by the prior treatment of cells with 8-Br-cGMP and furthermore it has been recently shown that 8-Br-cGMP slightly inhibited the agonist-induced InsP $ production in rat hepatocytes [30] . Although it has been shown in other cells types that cGMP could activate the Ca# + -ATPase [31] , we can eliminate the second hypothesis since we have shown, on permeabilized guinea-pig cells, that the Ca# + content of the ionomycin (or InsP $ )-sensitive Ca# + store(s) was not changed by the cGMP pretreatment (see the Results section).
Our data are consistent with an increase in the sensitivity of the Ca# + store(s) to the Ca# + -mobilizing effect of InsP $ . Indeed, the apparent affinity of the release mechanism for InsP $ was increased, as reflected by the shift to the left of the InsP $ dose-response curve. The pronounced enhancement of the response to low concentrations of InsP $ is likely to be responsible for the apparent increase in the sensitivity of cells to a subthreshold concentration either of noradrenaline or of photolytic release of InsP $ .
Implication of cGMP-dependent kinase
The InsP $ receptors also are a major substrate for cGMPdependent protein phosphorylation in smooth muscle and it was recently proposed that the phosphorylation could result in a diminished affinity for InsP $ [4] . However, it is known that phosphorylation processes can trigger opposite effects depending on the observed tissue and therefore it is conceivable that the liver type of InsP $ receptors may react differently after cyclic nucleotide-induced phosphorylation. The phosphorylation of InsP $ receptors by PKA has been shown to have opposing effects, i.e. a decrease in the InsP $ receptors' affinity to InsP $ in brain [5, 6] and, in contrast, an increase in hepatocytes [7, 27] . Thus, although cGMP and cAMP probably cross-interact on the activation of PKA and PKG (for a review, see [32] ), the specific action of PKG inhibitors on the cGMP effects confirmed the existence of a new pathway that could modulate the mobilization of intracellular Ca# + by hormones and neurotransmitters in guinea-pig hepatocytes.
Role of cGMP-evoked regulation of InsP 3 receptors in the cellular physiology
InsP $ -induced variations of [Ca# + ] i represent a main signal encoding cytosolic and nuclear functions, probably through the differential activation of Ca# + -binding proteins [33, 34] . Our results suggest that the InsP $ -evoked Ca# + release of hepatocytes is regulated by cGMP. Under these conditions, agents controlling the cGMP concentration may affect the InsP $ pathway and thus affect the cellular response. In many cell types the concentration of cGMP is controlled by soluble and membrane guanylate cyclases which are known to be respectively regulated by NO and peptides. These different pathways for stimulation of the cGMP production are likely to exist in the hepatocyte. Atrial natriuretic peptide, pancreastatin and epidermal growth factor regulate cGMP production in hepatocytes and are known to affect glycolytic metabolism and DNA synthesis [35] [36] [37] . NO is a diffusible messenger that can be released from surrounding cells or directly produced within the hepatocytes by the inducible NO synthase (iNOS) (reviewed in [38] ). The hepatic iNOS is induced by four factors acting simultaneously, lipopolysaccharide and the cytokines tumour necrosis factor, interleukin 1 and interferon γ [39] , thus suggesting that NO appears mainly after liver immunological disorders. NO activates a soluble hepatic guanylate cyclase and triggers an enhancement of the cGMP level [40] . NO is also known to promote deep modifications of the hepatic energetics and metabolism [41] [42] [43] [44] [45] . It is not clearly established whether all these modifications are strictly mediated by cGMP and whether they are correlated with a cGMP-dependent alteration of the InsP $ pathway. However, these observations, and the results shown here, strongly suggest that the cGMP-dependent modification of InsP $ receptor properties has a role as part of the liver's physiological and physio-pathological responses.
